Ryan Specialty Holdings
RYAN · NYSE
About RYAN
- Employees
- 6,144
- Headquarters
- Chicago, Illinois
- Listed
- Jul 22, 2021
- Sector
- Financials
- Industry
- Insurance
- Website
- ryanspecialty.com
RYAN key statistics
- Market cap
- 10.97B
- Price-earnings ratio
- 56.63
- Dividend yield
- 0.60%
- Average volume
- 1.91M
- Volume
- 2.19M
- Open price
- $41.18
- High today
- $42.91
- Low today
- $40.87
- 52 Week high
- $58.94
- 52 Week low
- $29.28
Ryan Specialty Holdings (RYAN) at a glance
As of Oct 20, 2026, Ryan Specialty Holdings (RYAN) shares are priced at $42.89, giving the company a market cap of 10.97B, a price-to-earnings ratio of 56.63 and a dividend yield of 0.60%.
Today the stock has traded between $40.87 and $42.91. The current price is 4.9% above the day's low and 0.0% below its high.
Volume so far is 2.19M shares, in line with the average of 1.91M shares a day.
Over the past year Ryan Specialty Holdings has ranged from $29.28 to $58.94, and now sits 46% of the way up that range.
Ryan Specialty Holdings met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported $0.74 per share against an estimate of $0.6122.
The average analyst price target is $52.28, 21.9% above the current price, from 17 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy47.1%
- Hold41.2%
- Sell11.8%
- Low
- $41.41
- Now
- $42.89
- High
- $79.80
RYAN earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 8 quarters, by 13.1% on average.
- Q3 FY24: reported $0.41 per share against an estimate of $0.4239
- Q4 FY24: reported $0.45 per share against an estimate of $0.4616
- Q1 FY25: reported $0.39 per share against an estimate of $0.399
- Q2 FY25: reported $0.66 per share against an estimate of $0.664
- Q3 FY25: reported $0.47 per share against an estimate of $0.4763
- Q4 FY25: reported $0.45 per share against an estimate of $0.5074
- Q1 FY26: reported $0.47 per share against an estimate of $0.4463
- Q2 FY26: reported $0.74 per share against an estimate of $0.6122
RYAN news
- Press releaseBusiness Wire
- Piero Cingari
Nasdaq 100 Flirts with Records, Oil Sinks for Fifth Day: Stock Market Today
- Press releaseBusiness Wire
Ryan Specialty Reports Second Quarter 2026 Results
- Press releaseBusiness Wire
Ryan Specialty Underwriting Managers Completes a Series of Lloyd’s Consortium Stamps to Support its Delegated Portfolio
- Press releaseBusiness Wire
Ryan Specialty to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
- Press releaseBusiness Wire
RT Specialty Announces Planned Leadership Succession
- Press releaseBusiness Wire
RYAN Investors Have Opportunity to Join Ryan Specialty Holdings, Inc. Fraud Investigation with the Schall Law Firm
- Press releaseBusiness Wire
AM Best Assigns Performance Assessment to Ryan Specialty (Singapore) Pte. Limited; Affirms Performance Assessment of Remaining Ryan Specialty Underwriting Managers' Affiliates
Similar companies
Companies in the same industry as Ryan Specialty Holdings
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.